Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

Abbott Laboratories ( ($ABT) ) has released its Q4 earnings. Here is a breakdown of the information Abbott Laboratories presented to its ...

nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Abbott will live-webcast its fourth-quarter earnings conference call through its ...

StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...

Reference tablets (Klacid®, Abbott Laboratories) released 94 to 95% of the drug in 30 minutes. Overall, 70% (28 of 40) of the generic products tested released less drug in 30 minutes than did the ...

4 Abbott's other technologies span the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 ...

A total of 60% (24 of 40) of the generic products tested exceeded the Abbott Laboratories' 3% limit for total impurities in bulk drug, and 70% (28 of 40) exceeded the Abbott Laboratories' 0.8% ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how ...